Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis

February 01, 2024

Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 12/8

December 08, 2023

Analyst Ratings for Cabaletta Bio ↗

November 29, 2023

Via Benzinga

Where Cabaletta Bio Stands With Analysts ↗

November 10, 2023

Via Benzinga

Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 11/9

November 09, 2023

Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

January 31, 2024

Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosis

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 22, 2024

Via Benzinga

January 08, 2024

Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

Cabaletta Bio: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 10/24

October 24, 2023

Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday ↗

December 07, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday.

Via Benzinga

Topics Stocks

Leslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 29, 2023

U.S. stock futures traded higher this morning, with the Dow Jones futures gaining around 100 points on Wednesday.

Via Benzinga

Topics Stocks

Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference

November 28, 2023

7 Analysts Have This to Say About Cabaletta Bio ↗

October 24, 2023

Via Benzinga

Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 10/23

October 23, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The...

The Latest Analyst Ratings for Cabaletta Bio ↗

October 04, 2023

Via Benzinga

Crude Oil Surges 2%; Tharimmune Shares Plummet ↗

November 28, 2023

Via Benzinga

Topics Stocks

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 28, 2023

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 28, 2023

Via Benzinga

Cantor Fitzgerald Maintains Overweight Rating for Cabaletta Bio: Here's What You Need To Know ↗

November 15, 2023

Via Benzinga

Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

November 09, 2023

Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle Platform

November 06, 2023

From Cellares

Via Business Wire

Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis

November 06, 2023

Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November

October 30, 2023

Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗

October 24, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023 ↗

October 19, 2023

Via Benzinga

October 02, 2023